Tumorassoziierte Fatigue

Fatigue (cancer-related fatigue (CRF)) ist eine der häufigsten Nebenwirkungen in Zusammenhang mit Krebserkrankungen oder deren Behandlung. Betroffene leiden häufig unter einer sehr eingeschränkten Lebensqualität. Um eine Chronifizierung zu vermeiden, ist eine frühzeitige Behandlung wichtig. Verschiedene non-pharmakologische Therapieansätze sind in der Behandlung hilfreich.

Publication History

Article published online:
20 February 2023

• Literatur

• 1 Deutsche Fatigue Gesellschaft e. V. (DFaG). Fatigue Therapiemanual. Köln: Im Internet: https://deutsche-fatigue-gesellschaft.de/
• 2 Berger AM, Mooney K, Alvarez-Perez A. et al. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw 2015; 13: 1012-1039 DOI: 10.6004/jnccn.2015.0122.
• 3 Horneber M, Fischer I, Dimeo F. et al. Cancer-Related Fatigue. Dtsch Ärztebl Internat 2012; 109: 161-171 DOI: 10.3238/arztebl.2012.0161.
• 4 Weis J, Horneber M. Definition and Prevalence of Cancer-Related Fatigue. Springer Healthcare, Tarporley 2015; 1-10 DOI: 10.1007/978–1-907673–76–4_1.
• 5 Weis J. Cancer-related fatigue: prevalence, assessment and treatment strategies. Expert Rev Pharmacoecon Outcomes Res 2011; 11: 441-446 DOI: 10.1586/erp.11.44.
• 6 Cella D, Davis K, Breitbart W. et al. Cancer-Related Fatigue: Prevalence of Proposed Diagnostic Criteria in a United States Sample of Cancer Survivors. JCO 2001; 19: 3385-3391 DOI: 10.1200/JCO.2001.19.14.3385.
• 7 Wu C, Zheng Y, Duan Y. et al. Nonpharmacological Interventions for Cancer-Related Fatigue: A Systematic Review and Bayesian Network Meta-Analysis. Worldviews Evid Based Nurs 2019; 16: 102-110 DOI: 10.1111/wvn.12352.
• 8 Ma Y, He B, Jiang M. et al. Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis. Int J Nurs Stud 2020; 111: 103707 DOI: 10.1016/j.ijnurstu.2020.103707.
• 9 Kuhnt S, Ernst J, Singer S. et al. Fatigue in cancer survivors--prevalence and correlates. Onkologie 2009; 32: 312-317 DOI: 10.1159/000215943.
• 10 Fabi A, Falcicchio C, Giannarelli D. et al. The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?. Breast 2017; 34: 44-52 DOI: 10.1016/j.breast.2017.04.012.
• 11 Fabi A, Bhargava R, Fatigoni S. et al. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol 2020; 31: 713-723 DOI: 10.1016/j.annonc.2020.02.016.
• 12 Howell D, Keshavarz H, Broadfield L. et al. A Pan Canadian Practice Guideline for Screening, Assessment, and Management of Cancer-Related Fatigue in Adults (Version 2). 2015 DOI: 10.7939/R33R6N Accessed November 30, 2022 at: https://era.library.ualberta.ca/items/8b8823da-1858–46f1-bb08–8811cd1a5a74
• 13 Smets EM, Garssen B, Bonke B. et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315-325 DOI: 10.1016/0022-3999(94)00125-o.
• 14 The European Organisation for Research and Treatment of Cancer Quality of Life Group (2016). https://qol.eortc.org/questionnaires
• 15 Mendoza TR, Wang XS, Cleeland CS. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85: 1186-1196 DOI: 10.1002/(sici)1097–0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n.
• 16 Bower JE. The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms. Cancer 2019; 125: 353-364 DOI: 10.1002/cncr.31790.
• 17 Thong MSY, van Noorden CJF, Steindorf K. et al. Cancer-Related Fatigue: Causes and Current Treatment Options. Curr Treat Options Oncol 2020; 21: 17 DOI: 10.1007/s11864-020-0707-5.
• 18 Mustian KM, Alfano CM, Heckler C. et al. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol 2017; 3: 961-968 DOI: 10.1001/jamaoncol.2016.6914.
• 19 Haussmann A, Schmidt M, Illmann M. et al. Meta-Analysis of Randomized Controlled Trials on Yoga, Psychosocial, and Mindfulness-Based Interventions for Cancer-Related Fatigue: What Intervention Characteristics Are Related to Higher Efficacy?. Cancers 2022; 14: 2016 DOI: 10.3390/cancers14082016.
• 20 Fatigue individuell bewältigen (FIBS): Schulungsmanual und Selbstmanagementprogramm für Menschen mit Krebs. 1. Aufl.. Bern: Huber; 2011